Hadasit Bio-Holdings

Press Releases

Immediate Report Concerning the Results of a Public Offering According to a Shelf Offer from March 30, 2015

Mar. 30, 2015

 

HBL – Hadasit Bio-Holdings Ltd.

(“the Company”)

 

To:

The Israel Securities Authority

www.isa.gov.il

To:

The Tel Aviv Stock Exchange Ltd.

www.tase.co.il

March 30, 2015

Re: An Immediate Report Concerning the Results of a Public Offering According to a Shelf Offer from March 30, 2015

In accordance to Section 30 of the Securities Law-1968, and the Securities Regulations (Notice of Results of the Offer in a Prospectus)-1969, the Company is hereby honored to announce the results of a public offering according to the shelf offer report the Company published on March 29, 2015 (henceforth: “the Shelf Offer Report”), in accordance to the Company’s shelf prospectus of June 25, 2012, as it was prepared on May 14, 2014 (Reference Numbers 2012-01-164475 and 2014-01-063108 respectively) (henceforth: “the Shelf Prospectus”)

1.    According to the Shelf Offer Report, the Company offered the following securities to the public:

1.1.   Up to 42,000,000 common Company shares, listed by name, having a nominal value of NIS 0.01 each (henceforth: “the Offered Shares”);

1.2.   Along with up to 42,000,000 options (Series 8), listed by name, that can be exercised for Company shares (henceforth: “Options (Series 8)”), so that every Option (Series 8) can be exercised for one common Company share at a nominal value of NIS 0.01, subject to adjustments detailed in Section 3.2.4 of the Shelf Offer Report, on every trading day beginning on the day of their listing for trade on the stock market, except at times detailed in Section 3.2.1 of the Shelf Offer Report, and until March 30, 2016 (included), against a cash payment of the exercising price totaling NIS 0.15 (not linked).


The Offered Shares and Options (Series 8) that were offered will henceforth be called together: “the Offered Securities”.

 

 

2.      The Offered Securities were offered to the public by a common stock offering in accordance to the Securities Regulations (Offer of Securities to the public)-2007, in 42,000 units (henceforth: “the Unit”or“the Units) by tender for the Unit’s price (henceforth: “the Tender”), where the minimum Unit price was NIS 135 (henceforth: “the Minimum Unit Price”), and the composition of each Unit is as follows:

Number of Securities in the Unit

Minimum Price for the Security

Total

1000 common shares

NIS 0.135 per share

NIS 135

1000 Options (Series 8)

--

--

The Minimum Unit Price

 

NIS 135

 

3.      The period for the submission of orders and purchasing the Units commenced on March 30, 2015, at 15:15 (3:15 PM) and closed the same day, at 17:30 (5:30 PM).

4.      The following are the results of the public offering according to the Shelf Offer Report:

4.1.   As part of the Tender, a total of 11 orders were received for the purchase of 32,932 Units, at a total monetary scope of NIS 4,568 thousand.

4.2.   The Unit price, that was set in the Tender, is NIS 135 (henceforth: “the Set Unit Price”), where a total of 32,932 Units were allocated.

4.3.   The allocation of Units in the Tender (including the additional allocation) was carried out in accordance to the Shelf Prospectus regulations, and were as follows:

4.3.1.                4 orders for the purchase of 3,400 Units, priced higher than the Set Unit Price, were completely filled.

4.3.2.               7 orders for the purchase of 29,532 Units, priced at the Set Unit Price, were completely filled.

5.      The immediate gross consideration received by the Company for the allocation of the securities offered to the public according to the Shelf Offer Report is NIS 4,445,820 thousand.

6.      The Units’ offering was not secured by underwriting.

 

The Company thanks the investors for accepting the offer.

 

Sincerely,

HBL – Hadasit Bio Holdings Ltd.

Tamar Kfir, CEO

 

 
 

Press Releases Archive